Come up with a name for your new list and we'll add to it:
Avila Therapeutics was acquired by
Celgene on January 29, 2012.
Avila Therapeutics is developing new medicines that achieve 'protein silencing' based on the proprietary Avilomics platform. Per the company, these medicines, called covalent drugs, strongly and resil…